You are here

  • Home
  • Archive
  • Volume 71, Issue 12
  • Updated meta-analysis of non-melanoma skin cancer rates reported from prospective observational studies in patients treated with tumour necrosis factor inhibitors

Article Text

Article menu
Download PDFPDF
Electronic pages
Updated meta-analysis of non-melanoma skin cancer rates reported from prospective observational studies in patients treated with tumour necrosis factor inhibitors

https://doi.org/10.1136/annrheumdis-2012-202478

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Competing interests XM has received research grants or honoraria from Bristol Myers Squibb, GSK, Pfizer and Roche; AR was an employee of Wyeth Europa and had held shares in Wyeth and currently has Pfizer share options, and has undertaken consultancy work for UCB Pharma and Pfizer; PE has received research grants or honoraria from Bristol Myers Squibb, GSK, Pfizer and Roche. This work was undertaken without external funding.

    • Provenance and peer review Not commissioned; internally peer reviewed.

    • Xavier Mariette, Marco Matucci-Cerinic, Karel Pavelka, Peter Taylor, Ronald van Vollenhoven, Rebecca Heatley, Claire Walsh, Richard Lawson, Alan Vaughan Reynolds, Paul Emery